Cite
Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States.
MLA
Wallace, Katrine L., et al. “Increasing Prevalence of Metastatic Castration-Resistant Prostate Cancer in a Managed Care Population in the United States.” Cancer Causes & Control, vol. 32, no. 12, Dec. 2021, pp. 1365–74. EBSCOhost, https://doi.org/10.1007/s10552-021-01484-4.
APA
Wallace, K. L., Landsteiner, A., Bunner, S. H., Engel-Nitz, N. M., & Luckenbaugh, A. N. (2021). Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States. Cancer Causes & Control, 32(12), 1365–1374. https://doi.org/10.1007/s10552-021-01484-4
Chicago
Wallace, Katrine L., Adrienne Landsteiner, Scott H. Bunner, Nicole M. Engel-Nitz, and Amy N. Luckenbaugh. 2021. “Increasing Prevalence of Metastatic Castration-Resistant Prostate Cancer in a Managed Care Population in the United States.” Cancer Causes & Control 32 (12): 1365–74. doi:10.1007/s10552-021-01484-4.